Journal of Research in Pharmacy Practice最新文献

{"title":"Strategic Role and Challenges of Community Pharmacists in SARS-CoV-2 Outbreak.","authors":"Debjyoti Talukdar,&nbsp;Satish Jankie,&nbsp;Shyam Sundar Pancholi,&nbsp;Arindam Chatterjee,&nbsp;Parveen Kumar,&nbsp;Madan Mohan Gupta","doi":"10.4103/jrpp.JRPP_20_131","DOIUrl":"10.4103/jrpp.JRPP_20_131","url":null,"abstract":"<p><p>This study highlights the importance of community pharmacists' strategic role in hindering the progression of the SARS-CoV-2 virus in the community setting and innovative measures to protect themselves. This article focuses on the features, control, and prevention of COVID-19 and social awareness measures of the pandemic. The means employed by the community pharmacist to safeguard his health while providing pharmaceutical services during COVID-19 is compiled and presented to benefit health-care professionals around the world. As per the US Center for Disease Control and Prevention, community pharmacists play a crucial role in providing essential drugs to patients without knowing their current COVID-19 status. They also work in conditions that make them susceptible to COVID-19 exposure. Despite the availability of guidelines, community pharmacists need to be trained in personal protective equipment for efficient protection and prevention of spread. Community pharmacists are essential frontline warriors against transmission of the SARS-CoV-2 virus in the community and act as frontline workers to educate the public on COVID-19. They are at high risk and need to observe necessary precautions to mitigate the spread of the virus.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"10 1","pages":"1-9"},"PeriodicalIF":1.0,"publicationDate":"2021-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/63/9f/JRPP-10-1.PMC8259598.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39210675","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Clinical Characteristics, Medication Prescription Pattern, and Treatment Outcomes at the Neonatal Intensive Care Unit of a Tertiary Health-Care Facility in Ghana.","authors":"Kwame Opare-Asamoah, George Asumeng Koffuor, Alhassan Abdul-Mumin, Baba Mohammed Sulemana, Majeed Saeed, Lawrence Quaye","doi":"10.4103/jrpp.JRPP_20_118","DOIUrl":"10.4103/jrpp.JRPP_20_118","url":null,"abstract":"<p><strong>Objective: </strong>Neonates are more susceptible to infections, as well as medication toxicities. This study, therefore, sought to describe the clinical characteristics, medication prescription pattern, and treatment outcomes for neonates admitted to the neonatal intensive care unit (NICU) of a tertiary health-care facility in Ghana.</p><p><strong>Methods: </strong>A retrospective cross-sectional study was conducted to ascertain clinical records, conditions for admission, spectrum of medications prescribed, and treatment outcomes from neonatal patient folders.</p><p><strong>Findings: </strong>Of 667 folders reviewed (51.4% males and 48.6% female), 61.8% were preterm (mean gestational age: 34.2 ± 3.6 weeks), 64.6% had low birth weight (LBW) (mean birth weight: 2.1 ± 0.9 kg), 90.6% were delivered through spontaneous vaginal delivery, and 57.4% delivered at the tertiary health-care facility. Of the 667 neonates, 70%, 27.1%, and 2.9% were queried with one, two, or three medical conditions, respectively. Respiratory distress, preterm, and pyrexia were common single queried conditions (88.5%). LBW, hypothermia, and single queried medical conditions were associated (<i>P</i> ≤ 0.0001) with preterm male neonates. The mean duration of stay of preterm neonates was 3.5 ± 3.2 days (term babies: 1-2 days [<i>P</i> = 0.0085]). Of 1,565 medications prescribed to the 667 neonates, 67.5% were antibacterial, with gentamicin (53.0%) being the most prescribed. 98.4% of neonates were prescribed at least one medication (i.e., 67.5% were prescribed antibacterial medications, 14.6% supplements, 11.0% bronchodilators, and 7.0% antiseizure); mean medication combination 2.6 ± 0.8 per neonate. Majority (75.4%) of the cases reviewed had treatment success.</p><p><strong>Conclusion: </strong>Respiratory distress and preterm deliveries are predominant presenting conditions, with antibacterial medication, mainly gentamicin and ampicillin, on prescription. Treatment success is significantly high at the NICU.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"10 1","pages":"30-37"},"PeriodicalIF":1.0,"publicationDate":"2021-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a3/88/JRPP-10-30.PMC8259601.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39210679","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Exploring Cypriot Pharmacists' Perceptions about their Role in Cardiovascular Disease Prevention: A Descriptive Qualitative Study.","authors":"Periklis Charalampous,&nbsp;Aliki Peletidi","doi":"10.4103/jrpp.JRPP_20_102","DOIUrl":"https://doi.org/10.4103/jrpp.JRPP_20_102","url":null,"abstract":"<p><strong>Objective: </strong>The age-standardized prevalence of cardiovascular diseases (CVDs) among the Cypriot population in 2017 was estimated to be 5552 per 100,000. Therefore, the CVD prevention in Cyprus is of paramount importance. Pharmacists are one of the most accessible health-care professionals (HCPs) and the first port of call for the public. In Cyprus, there are 55.59 pharmacies per 100,000 inhabitants. Therefore, the role of Cypriot pharmacists (CPs) in primary CVD prevention is essential. This study aimed to explore both the existing and potential future roles of CPs in CVD prevention.</p><p><strong>Methods: </strong>A descriptive qualitative study employing structured interviews (SIs) was conducted. Initially, the CPs were identified through a list provided by the Cypriot Pharmaceutical Services. The researcher(s) then contacted CPs by telephone. Face-to-face interviews were scheduled based on the CP's availability. In total, 21 SIs were transcribed verbatim, coded, and analyzed thematically. SIs continued until data saturation was achieved.</p><p><strong>Findings: </strong>The findings are reported under the themes of pharmacists' knowledge and role, resources/tools available and training, communication and relations, and barriers. CPs expressed the need for training, and they are ready to have a more proactive role within the primary health care. The main barrier identified was the lack of responsiveness of the public and the lack of CP's time.</p><p><strong>Conclusion: </strong>CPs have the potential to actively participate in CVD prevention in Cyprus. CPs want to start offering primary CVD health services, with the smoking cessation being the first intervention.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"10 1","pages":"23-29"},"PeriodicalIF":1.0,"publicationDate":"2021-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/4b/f0/JRPP-10-23.PMC8259602.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39210678","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Statin Type and Cancer Outcomes in Patients with Diabetes Type 2 and Solid Tumors.","authors":"Alice C Ceacareanu, Shanria D Jolly, George K Nimako, Zachary A P Wintrob","doi":"10.4103/jrpp.JRPP_21_3","DOIUrl":"10.4103/jrpp.JRPP_21_3","url":null,"abstract":"<p><strong>Objective: </strong>Type 2 diabetes mellitus (T2DM) affects 10% of Americans and is associated with an increased incidence of cancer. Statins are first-line cholesterol-lowering medications in the treatment of hyperlipidemia. Several studies have demonstrated a relationship between statin use and reduced cancer incidence. We examined the cancer benefits of statin subtypes, with specific attention to disease-free survival (DFS) and overall survival (OS).</p><p><strong>Methods: </strong>This retrospective review included adults with T2DM diagnosed with solid tumors at Roswell Park Cancer Institute in Buffalo, NY, USA (2003-2010). Individuals with gestational diabetes, incomplete records, or diagnosed with rare solid tumors were excluded. Follow-up began at the date of diagnosis and ended with the first confirmed recurrence, death, or loss of contact. Demographics were assessed by Chi-square, Kaplan-Meier survival analyses, and Cox proportional hazards regression.</p><p><strong>Findings: </strong>Overall, 1102 patients met inclusion criteria, 52.1% of the study participants were female, and 578 participants (52.5%) died during the follow-up period which ranged from 0 to 156 months. Hydrophilic statin use was associated with improved DFS at 5-year follow-up (41.0% vs. 36.9%, <i>P</i> = 0.0077) compared to lipophilic statin use. Multivariate regression revealed that hydrophilic statins were associated with improved DFS (hazard ratio [HR]: 0.706, 95% confidence interval [CI]: 0.526-0.947) and OS (HR: 0.685, 95% CI: 0.503-0.934). Pravastatin was associated with improved OS (HR: 0.674, 95% CI: 0.471-0.964).</p><p><strong>Conclusion: </strong>In patients with T2DM and cancer, hydrophilic statins, and pravastatin in particular, are associated with improved DFS as well as OS. Further research examining the cancer-specific effects of hydrophilic and lipophilic statins is needed to better understand their beneficial effects.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"10 1","pages":"50-56"},"PeriodicalIF":0.8,"publicationDate":"2021-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/16/4a/JRPP-10-50.PMC8259595.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39215055","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comparing the Effect of a Herbal-based Laxative (Goleghand®) and Polyethylene Glycol on Functional Constipation among Children: A Randomized Controlled Trial.","authors":"Hosein Saneian,&nbsp;Saeedeh Ghaedi,&nbsp;Fatemeh Famouri,&nbsp;Majid Khademian,&nbsp;Najmeh Ahmadi,&nbsp;Mohammadreza Memarzadeh,&nbsp;Somayeh Sadeghi,&nbsp;Peiman Nasri","doi":"10.4103/jrpp.JRPP_20_133","DOIUrl":"https://doi.org/10.4103/jrpp.JRPP_20_133","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to evaluate the effectiveness, safety, and document the reported adverse effect of a herbal-based laxative (Goleghand^®) for the maintenance treatment of functional constipation in young children.</p><p><strong>Methods: </strong>We conducted a randomized clinical trial from April 2019 to September 2020. Children aged 2-15 years with functional constipation defined according to the Rome IV criteria were eligible for study inclusion. Eligible children were randomly allocated to receive polyethylene glycol (PEG) or Goleghand^®. The number and consistency of stools per day, painful defecation, abdominal pain, and fecal incontinence were reported weekly by parents. The statistical analyses were performed by determining means and standard deviations, <i>t</i>-test, Chi-square test, ANOVA repeated measures, and Fisher's exact test, with significance, accepted at the 5% level.</p><p><strong>Findings: </strong>Sixty patients have been enrolled in the study. Parental satisfaction scores did not change significantly in either group or over the follow-up period. Our results showed that the effect of time (<i>P</i> < 0.001) and also the effect of group type (<i>P</i> = 0.01) on the number of fecal defecations was significant. The mean number of defecations increased first and then decreased significantly over time, but this decrease was more significant in the PEG group than in the Goleghand^® group (<i>P</i> = 0.001). Furthermore, the effect of time on the fecal consistency score was significant (<i>P</i> = 0.047). The mean score of fecal consistency in both groups decreased over time.</p><p><strong>Conclusion: </strong>Goleghand^® was similar in efficacy to PEG for 8 weeks of pediatric functional constipation treatment in this randomized clinical trial. Goleghand^® can be considered as a new herbal laxative drug for pediatric functional constipation.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"10 1","pages":"43-49"},"PeriodicalIF":1.0,"publicationDate":"2021-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/9f/8e/JRPP-10-43.PMC8259596.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39215053","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Effectiveness of Plasmapheresis in Aluminum Phosphate Poisoning.","authors":"Shiva Samsam Shariat,&nbsp;Shafeajafar Zoofaghari,&nbsp;Farzad Gheshlaghi","doi":"10.4103/jrpp.JRPP_21_27","DOIUrl":"https://doi.org/10.4103/jrpp.JRPP_21_27","url":null,"abstract":"1. Tawfik HM. Recent advances in management of aluminium phosphide poisoning. QJM Int J Med 2020;113 Suppl 1:hcaa049.002. [doi: https://doi.org/10.1093/ qjmed/hcaa049.002]. 2. Elgazzar FM. Assessment of Intravenous lipid emulsion as an adjuvant therapy in acute aluminum phosphide poisoning: A randomized controlled trial. QJM Int J Med 2020;113 Suppl 1:hcaa049.001. [doi: https://doi.org/100.1093/ qjmed/hcaa049.001]. 3. Gheshlaghi F, Lavasanijou MR, Moghaddam NA, Khazaei M, Behjati M, Farajzadegan Z, et al. N-acetylcysteine, ascorbic acid, and methylene blue for the treatment of aluminium phosphide poisoning: Still beneficial? Toxicol Int 2015;22:40‐4. 4. Dorooshi G, Zoofaghari S, Mood NE, Gheshlaghi F. A newly proposed management protocol for acute aluminum phosphide poisoning. J Res Pharm Pract 2018;7:168-9. 5. Moghadamnia AA. An update on toxicology of aluminum phosphide. Daru 2012;20:25. 6. Tahergorabi Z, Zardast M, Naghizadeh A, Mansouri B, Nakhaei I, Zangouei M. Effect of aluminium phosphide (ALP) gas inhalation exposure on adipose tissue characteristics and histological toxicity in male rats. J Taibah Univ Sci. 2020;14:1317-25. Letter to the Editor","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"10 1","pages":"57"},"PeriodicalIF":1.0,"publicationDate":"2021-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f8/42/JRPP-10-57.PMC8259597.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39215056","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Review of COVID-19 Treatment.","authors":"Somayeh Sadeghi,&nbsp;Mahnaz Momenzadeh,&nbsp;Peiman Nasri,&nbsp;Mina Nickpour","doi":"10.4103/jrpp.JRPP_20_72","DOIUrl":"https://doi.org/10.4103/jrpp.JRPP_20_72","url":null,"abstract":"<p><p>Many contagious diseases, such as plague or cholera, played a role in changing the pathway of history. In this respect, although coronavirus was not as dangerous as novel diseases such as swine flu and Ebola, the spread and the power of coronavirus infiltration caused public fear across the world. Three viruses among coronaviruses have been epidemic during the recent years, including severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and COVID-19 or new coronavirus. Respiratory droplets transmit the coronavirus through direct and indirect contact, and it can be transmitted through the contact in the case of remaining, the infected person's secretion on the surface. Based on the conducted studies on the treatment of COVID-19 disease, there is virtually no cure or vaccine for coronavirus infections yet. Those infected with Covid 19 are quarantined to prevent the outbreak of this disease. However, the researchers carried out different studies to investigate the impact of the various drugs on this virus, which in this study, we will examine the outline of this disease and the other conducted studies.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"9 4","pages":"169-174"},"PeriodicalIF":1.0,"publicationDate":"2021-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f3/cb/JRPP-9-169.PMC8067900.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38919309","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Assessment of Medication Adherence in Patients with Chronic Diseases in Tabuk, Kingdom of Saudi Arabia.","authors":"Kousalya Prabahar,&nbsp;Maymonah Abdullah Albalawi,&nbsp;Lama Almani,&nbsp;Sarah Alenizy","doi":"10.4103/jrpp.JRPP_20_97","DOIUrl":"https://doi.org/10.4103/jrpp.JRPP_20_97","url":null,"abstract":"<p><strong>Objective: </strong>Uncontrolled chronic diseases such as hypertension and diabetes mellitus can lead to severe complications. Poor adherence to medication is one of the important reasons, leading to complications for chronically diseased patients. We aimed to assess the trend toward medication adherence and the reasons for medication nonadherence in chronic disease patients in Tabuk city in Saudi Arabia.</p><p><strong>Methods: </strong>A cross-sectional study was conducted at a tertiary care hospital in Tabuk, Saudi Arabia. Participants were selected and interviewed for information regarding their medication adherence. A medication adherence rating scale questionnaire was used to measure the level of adherence in study participants. The data were analyzed by the statistical package for the social sciences (SPSS) database 24.</p><p><strong>Findings: </strong>Overall, 208 participants were involved in this study. Among these, 134 (64.4%) were female, and 74 (35.6%) were male. This study showed that 159 (76.44%) participants were adherent to their medications and nearly one-quarter of patients were nonadherent to their medications. No statistically significant differences were found between male and female patients toward their medication adherence. The primary intentional and nonintentional reason for nonadherence was side effects and forgetfulness, respectively.</p><p><strong>Conclusion: </strong>Tailoring the therapy according to the individual need of the patients will maximize the patient's adherence toward medications.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"9 4","pages":"196-201"},"PeriodicalIF":1.0,"publicationDate":"2021-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ed/20/JRPP-9-196.PMC8067897.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38919312","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The COVID-19 Vaccine Saga: A Perspective.","authors":"Shashank M Patil, Ramith Ramu","doi":"10.4103/jrpp.JRPP_20_100","DOIUrl":"10.4103/jrpp.JRPP_20_100","url":null,"abstract":"","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"9 4","pages":"218-219"},"PeriodicalIF":1.0,"publicationDate":"2021-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b8/0a/JRPP-9-218.PMC8067902.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38839400","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Common Opioids Involved in Drug Poisoning Presenting to the Emergency Department: A Cross-sectional Study.","authors":"Nastaran Eizadi-Mood,&nbsp;Elham Haghshenas,&nbsp;Ali Mohammad Sabzghabaee,&nbsp;Ahmad Yaraghi,&nbsp;Ziba Farajzadegan","doi":"10.4103/jrpp.JRPP_20_105","DOIUrl":"https://doi.org/10.4103/jrpp.JRPP_20_105","url":null,"abstract":"<p><strong>Objective: </strong>Opioids poisoning is of the most important cause of mortality. The objective of the study was to compare the demographic factors, clinical manifestations, and outcomes of the most common opioids involved in drug overdose presenting to the Emergency Department.</p><p><strong>Methods: </strong>This cross-sectional study was conducted from October 2016 to March 2017 in the Clinical Toxicology Department of the main referral center of the university. All poisoning cases with common opioids were included in the study. Demographic factors, clinical manifestations, and outcome were recorded in a check list. ANOVA, Chi-square or Fisher's exact test, and binary logistic regression analysis were used for outcome prediction.</p><p><strong>Findings: </strong>Two hundred and thirty six patients with opioids poisoning were evaluated during the study period. The most common opioids involved in poisoning were methadone (47.9%), tramadol (24.2%), and opium (21.6%). Patients with opium poisoning were older than others (<i>P</i> < 0.0001). The rate of suicide was more in the tramadol group, while the past history of psychological problems was more observed in the methadone group (<i>P</i> < 0.0001). Increasing age (odds ratio [OR], 1.05; 95% confidence interval [CI]: 1.02-1.09; <i>P</i> = 0.05) and addiction (<i>P</i> = 0.01; OR, 7; 95% CI: 1.55-31.52) was associated with an increased complications or death. Also patients with somatic disease had more chance of complications/death (<i>P</i> = 0.04; OR, 3.71; 95% CI: 1.06-12.97). Kind of opioids was not a predictive factor in the outcome of the patients with acute poisoning.</p><p><strong>Conclusion: </strong>Age, addiction, and somatic disease should be considered as more important factors in outcome prediction with opioids poisoning, including opium, tramadol, and methadone.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"9 4","pages":"202-207"},"PeriodicalIF":1.0,"publicationDate":"2021-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c8/63/JRPP-9-202.PMC8067901.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38839403","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}